{"id":"https://openalex.org/W7127709151","doi":"https://doi.org/10.1158/1078-0432.31248833","title":"Supplementary Table S4 from Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Cancer","display_name":"Supplementary Table S4 from Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Cancer","publication_year":2026,"publication_date":"2026-02-04","ids":{"openalex":"https://openalex.org/W7127709151","doi":"https://doi.org/10.1158/1078-0432.31248833"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.31248833","doi":"https://doi.org/10.1158/1078-0432.31248833","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.31248833","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.31248833","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5125092357","display_name":"Alexander Armstrong","orcid":"https://orcid.org/0009-0003-6957-9903","observed_orcids":["https://orcid.org/0009-0003-6957-9903"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Armstrong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-6957-9903","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115514900","display_name":"Graziella van der Plancke","orcid":"https://orcid.org/0009-0008-2168-4006","observed_orcids":["https://orcid.org/0009-0008-2168-4006"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Graziella van der Plancke","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-2168-4006","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125042194","display_name":"Sae Nishiguchi","orcid":"https://orcid.org/0009-0002-2356-0409","observed_orcids":["https://orcid.org/0009-0002-2356-0409"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sae Nishiguchi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-2356-0409","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036279577","display_name":"Diego Salas\u2010Benito","orcid":"https://orcid.org/0000-0002-8995-1499","observed_orcids":["https://orcid.org/0000-0002-8995-1499"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diego Salas-Benito","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8995-1499","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073324722","display_name":"Amanda A. Bouffard","orcid":"https://orcid.org/0009-0003-1501-4384","observed_orcids":["https://orcid.org/0009-0003-1501-4384"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda A. Bouffard","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-1501-4384","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112850512","display_name":"Sadie Goncalves","orcid":"https://orcid.org/0009-0005-0083-3699","observed_orcids":["https://orcid.org/0009-0005-0083-3699"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sadie Goncalves","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-0083-3699","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125044813","display_name":"Ashlyn T. Merce","orcid":"https://orcid.org/0009-0002-8583-0531","observed_orcids":["https://orcid.org/0009-0002-8583-0531"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashlyn T. Merce","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-8583-0531","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110082813","display_name":"Christopher Kelly","orcid":"https://orcid.org/0009-0006-6220-4588","observed_orcids":["https://orcid.org/0009-0006-6220-4588"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher Kelly","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-6220-4588","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063067098","display_name":"Filippo Birocchi","orcid":"https://orcid.org/0000-0002-5214-233X","observed_orcids":["https://orcid.org/0000-0002-5214-233X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Filippo Birocchi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5214-233X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125074339","display_name":"Sangwoo Park","orcid":"https://orcid.org/0000-0002-2701-3114","observed_orcids":["https://orcid.org/0000-0002-2701-3114"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sangwoo Park","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2701-3114","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012987786","display_name":"Mark B. Leick","orcid":"https://orcid.org/0000-0003-3111-0221","observed_orcids":["https://orcid.org/0000-0003-3111-0221"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark B. Leick","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3111-0221","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073757407","display_name":"Nora Horick","orcid":"https://orcid.org/0000-0002-4355-5853","observed_orcids":["https://orcid.org/0000-0002-4355-5853"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nora Horick","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4355-5853","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030394595","display_name":"Trisha R. Berger","orcid":"https://orcid.org/0000-0003-3439-3239","observed_orcids":["https://orcid.org/0000-0003-3439-3239"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Trisha R. Berger","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3439-3239","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029763484","display_name":"Marcela Valderrama Maus","orcid":"https://orcid.org/0000-0002-7578-0393","observed_orcids":["https://orcid.org/0000-0002-7578-0393"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marcela V. Maus","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7578-0393","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5082467825","display_name":"Giulia Escobar","orcid":"https://orcid.org/0000-0001-9177-0251","observed_orcids":["https://orcid.org/0000-0001-9177-0251"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giulia Escobar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9177-0251","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.926800012588501,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.926800012588501,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.029200000688433647,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.017899999395012856,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9860000014305115},{"id":"https://openalex.org/keywords/mesothelin","display_name":"mesothelin","score":0.9470000267028809},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9869999885559082},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8450000286102295},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.847000002861023}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.9585000276565552},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7502999901771545},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.7132999897003174},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.605400025844574},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5138000249862671},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45820000767707825},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.45190000534057617},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.4230000078678131},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3149000108242035},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3068999946117401},{"id":"https://openalex.org/C2986587452","wikidata":"https://www.wikidata.org/wiki/Q938438","display_name":"Statistical analysis","level":2,"score":0.27230000495910645},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.25589999556541443}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.31248833","doi":"https://doi.org/10.1158/1078-0432.31248833","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.31248833","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.31248833","doi":"https://doi.org/10.1158/1078-0432.31248833","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.31248833","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4416174461","https://openalex.org/W7127631431","https://openalex.org/W2106837613","https://openalex.org/W2464744894","https://openalex.org/W2591113434","https://openalex.org/W4361237549","https://openalex.org/W4387566680","https://openalex.org/W4313406776","https://openalex.org/W2519462320","https://openalex.org/W2564127052"],"abstract_inverted_index":{"Supplementary":[0],"Table":[1],"4.":[2],"The":[3],"results":[4],"of":[5,16],"the":[6],"statistical":[7],"analysis":[8],"used":[9],"to":[10],"assess":[11],"additive":[12],"vs":[13],"synergistic":[14],"effect":[15],"ibrutinib":[17],"in":[18],"combination":[19],"with":[20],"CAR-T":[21],"cells":[22],"is":[23],"shown":[24],"for":[25],"Fig":[26],"5B.":[27]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-02-06T00:00:00"}